Catherine Anne Abbott

Title: Catherine Anne Abbott: Innovator in Peptide Research

Introduction

Catherine Anne Abbott is a notable inventor based in Belair, South Australia. She has made significant contributions to the field of peptide research, particularly in the area of dipeptidyl peptidases. Her work has implications for various applications in biochemistry and medicine.

Latest Patents

Catherine holds a patent that focuses on dipeptidyl peptidases, specifically peptides including HisGlyTrpSerTyrGlyGlyPheLeu, LeuAspGluAsnValHisPhePhe, GluArgHisSerIleArg, and PheValIleGlnGluGluPhe. These peptides demonstrate peptidase ability and exhibit substrate specificity for compounds such as H-Ala-Pro-pNA, H-Gly-Pro-pNA, and H-Arg-Pro-pNA. Additionally, her patent claims nucleic acids, vectors, antibodies, and hybridoma cells related to these sequences and their functionalities.

Career Highlights

Catherine's career is marked by her innovative research and dedication to advancing the understanding of peptide interactions. Her work has contributed to the scientific community's knowledge of enzyme specificity and substrate interactions.

Collaborations

Catherine has collaborated with Mark Douglas Gorrell, enhancing her research through shared expertise and insights. Their partnership has likely fostered advancements in their respective fields.

Conclusion

Catherine Anne Abbott is a pioneering inventor whose work in peptide research has led to valuable patents and collaborations. Her contributions continue to influence the scientific landscape in biochemistry and related disciplines.